najlaa hadi | Optical | Breakthrough Research Award

Published on by Molecular Biologist

Assist. Prof. Dr. najlaa hadi | Optical | Breakthrough Research Award 

Assistant Professor, at ministry of higher education , Iraq.

Dr. Najlaa Mohammed Hadi Mohammed Awad, born on March 14, 1977, in Hilla, Iraq, is a distinguished physicist and academician. Currently serving as an Assistant Professor at the Department of Physics, College of Education for Pure Sciences, University of Babylon, she has dedicated her career to advancing the field of physics. With a robust academic background and a passion for research, Dr. Awad has contributed significantly to the scientific community through her teaching, research, and publications. Her areas of expertise encompass atmospheric physics and physical optics, reflecting her diverse interests and commitment to interdisciplinary studies. Beyond her academic pursuits, she is known for her mentorship and dedication to fostering the next generation of scientists. Dr. Awad’s work continues to inspire and influence both her peers and students alike.

Professional Profile

Scopus

Google Scholar

🎓 Education 

Dr. Awad’s academic journey commenced with a Bachelor’s degree in Physics from the University of Kufa, College of Education for Women, in 1999. Her pursuit of knowledge led her to obtain a Master’s degree in Physics, specializing in Atmospheric Physics, from the University of Babylon, College of Education for Pure Sciences, in 2013. Demonstrating an unwavering commitment to her field, she achieved a Ph.D. in Philosophy in Physics, focusing on Physical Optics, from the same institution in 2024. Her educational background lays a solid foundation for her research endeavors and teaching methodologies. Dr. Awad’s academic progression reflects her dedication to continuous learning and her desire to contribute meaningfully to the scientific community through both theoretical and applied physics.

💼 Experience 

With a career spanning over two decades, Dr. Awad has amassed extensive experience in both academic and research settings. She has been a pivotal member of the Department of Physics at the University of Babylon, where she imparts knowledge to undergraduate and postgraduate students. Her teaching portfolio includes courses in general physics, atmospheric phenomena, and optical physics. Beyond teaching, she actively participates in curriculum development and academic advising, ensuring that the department’s offerings remain current and comprehensive. Dr. Awad’s experience is not limited to the classroom; she has also been involved in various research projects, contributing to the advancement of physics through her studies and publications. Her commitment to education and research underscores her role as a dedicated educator and scientist.

🔬 Research Interests 

Dr. Awad’s research interests are deeply rooted in the realms of atmospheric physics and physical optics. Her work often explores the interaction between light and atmospheric particles, investigating phenomena such as light scattering, absorption, and the impact of atmospheric conditions on optical measurements. She is particularly interested in the development of optical sensors and instruments designed to monitor environmental parameters. Her research contributes to a better understanding of atmospheric processes and aids in the development of technologies for environmental monitoring and assessment. Dr. Awad’s interdisciplinary approach bridges the gap between theoretical physics and practical applications, reflecting her commitment to research that has tangible benefits for society.

🏆 Awards & Recognitions 

Throughout her illustrious career, Dr. Awad has been the recipient of several awards and recognitions that underscore her contributions to physics and education. Her research excellence has been acknowledged through various academic honors, including best paper awards at national conferences. She has also received commendations for her innovative teaching methods and dedication to student success. Her peers recognize her as a leading figure in her field, often inviting her to speak at seminars and workshops. These accolades reflect not only her scientific acumen but also her commitment to nurturing the academic growth of her students and contributing to the broader scientific community.

📚 Top Noted Publications 

Dr. Awad has an impressive portfolio of 15 published research papers, contributing significantly to the fields of atmospheric physics and physical optics. Her work is featured in reputable journals and conference proceedings, reflecting the quality and impact of her research. Some of her notable publications include:

1. Study the Effect of Heat Treatment and Pressure on Some of the Optical Properties of the Pure PVA Nanopolymer

  • Journal: Key Engineering Materials

  • Year: 2021

  • Focus: Investigates how varying heat treatment and pressure influence the optical properties of pure PVA (Polyvinyl Alcohol) nanopolymer.

  • Key Findings:

    • Heat and pressure significantly affect optical transmittance and refractive index.

    • Thermal treatment leads to changes in molecular alignment and crystallinity.

  • Impact: Useful for tailoring PVA’s optical behavior for optoelectronic applications.

  • Cited by: 5 articles

  • Access: [Link to Article]

2. The Structural Properties of the Pure PVA Nanopolymer

  • Journal: Materials Today: Proceedings

  • Year: 2021

  • Focus: Detailed study on the structural characteristics of pure PVA nanopolymer using techniques like XRD and SEM.

  • Key Findings:

    • Identifies the degree of crystallinity and nanostructure uniformity.

    • Highlights temperature-related morphological changes.

  • Relevance: Foundational for understanding the behavior of PVA under mechanical or thermal stress.

  • Cited by: 3 articles

  • Access: [Link to Article]

3. A Study of the Physical Properties of Nanoscale Dental Fillings

  • Journal: Journal of University of Babylon for Pure and Applied Sciences

  • Year: 2023

  • Focus: Explores the physical behavior (mechanical strength, hardness, durability) of nanoscale dental composite materials.

  • Key Findings:

    • Enhanced performance with nano-fillers in dental resin composites.

    • Promising material stability under oral conditions.

  • Application: Dental materials design, nanocomposite development.

  • Cited by: 2 articles

  • Access: [Link to Article]

Conclusion

Dr. Najlaa Mohammed Hadi Mohammed Awad is a committed and qualified academic with notable experience in physics, including 15 publications and a recent Ph.D. in Physical Optics. Her interdisciplinary background in both atmospheric and optical physics provides a solid foundation for scientific contribution.

Aida Zaabtia | Chemistry | Best Researcher Award

Published on by Molecular Biologist

Dr. Aida Zaabtia | Chemistry | Best Researcher Award 

Dr. Aida Zaabtia at University of Gabes Faculty of Sciences of Gabes, Tunisia.

Aida ZAABTIA is a dedicated Tunisian researcher specializing in environmental and materials chemistry, with a growing academic presence in the field of water treatment. 🌍🔬 Born on January 21, 1999, in Gabes, Tunisia, Aida pursued a Bachelor’s degree in Chemistry followed by a Master’s in Materials and Environmental Chemistry at the Faculty of Sciences of Gabès. Currently, she is advancing her expertise through a Ph.D. program in the same institution, focusing on water treatment techniques, particularly the electro-Fenton process. 💧 She has demonstrated strong analytical chemistry skills, participated in impactful scientific research projects, and contributed to multiple international conferences and journals. Aida is also active in academic publishing and peer reviewing, showcasing her commitment to scientific rigor and innovation. With a focus on sustainable solutions to environmental issues, she aims to merge practical research with societal needs in Tunisia and beyond. 🌱📘

Professional Profile

Scopus

ORCID

🎓 Education

Aida’s academic journey is rooted in chemistry and environmental sciences. 🧪 She earned her Bachelor of Science in Chemistry from the Faculty of Sciences of Gabès in 2021. Following this, she completed a Master’s degree in Materials and Environmental Chemistry (2021–2023), where her dissertation focused on the “Treatment of Indigo Carmine by Electro-Fenton in the Presence of Pyrite.” Her current pursuit is a Ph.D. in Chemistry, with a specialization in water treatment, which she began in October 2023. Aida’s secondary education culminated in a Baccalauréat in Experimental Sciences in 2018 at Lycée Houssine Bouzaiene, Gafsa. Throughout her academic progression, she has cultivated skills in experimental design, data analysis, and chemical process optimization. 🎓📊 This solid foundation in both theoretical and applied chemistry positions her as a competent researcher in the fight against environmental pollution.

🧪 Experience

Aida has accumulated meaningful laboratory and field experience in environmental chemistry. From June to September 2023, she interned at the Faculty of Sciences of Gabès, where she conducted experiments using the electro-Fenton process for dye removal and analyzed data with advanced tools. 🧫💻 In July 2020, she worked in the Medical Analysis Laboratory at Hôpital Houssine Bouzayen in Gafsa, performing and interpreting biological tests such as complete blood counts and chemistries. In August 2020, she joined the Tunisian Chemical Group in Gafsa, conducting experiments to evaluate the effectiveness of chemical treatments and contributing to the analysis of processing methods. ⚗️🔍 Aida’s professional experience highlights her capacity to operate independently in high-stakes laboratory settings while collaborating within multidisciplinary research teams.

🔬 Research Interests

Aida’s primary research interests lie at the intersection of water treatment technologies, electrochemical oxidation, and environmental chemistry. 🌿🔬 Her current Ph.D. research focuses on optimizing the electro-Fenton process using solar energy for the degradation of organic pollutants in water systems. She is also exploring the treatment of complex effluents such as olive mill wastewater using coagulation–flocculation and electrochemical techniques. Other key areas include the design of advanced oxidation processes, analytical characterization of pollutants, and the application of green chemistry to mitigate industrial wastewater contamination. 🌞💧 Additionally, she has a growing interest in experimental design methodologies (e.g., Box-Behnken design) for optimizing treatment parameters, aiming to enhance both cost-efficiency and environmental sustainability. Aida’s long-term vision is to bridge the gap between laboratory innovation and real-world applications, especially in arid and semi-arid regions like Tunisia.

🏆 Awards & Recognitions

Aida has built an impressive portfolio of academic and professional certifications. 🏅 She holds a Neuro-Linguistic Programming (NLP) certificate and a Quality Management Systems (ISO 9001:2015) certification from British Safety Services (BSS). She actively participates in major scientific gatherings, including the 9th Mediterranean Conference on Desalination and Water Treatment (2024) and the GEME1 conference (2024). 🧠📊 In 2023, she attended the conference-debate on scientific and technical monitoring and the international meeting “Water in the Desert”. In 2025, she took on roles as an academic board member for the Global Open Share Publishing (GOSP) and as an online reviewer for the Environmental Engineering and Management Journal. These achievements reflect her rising status as an emerging expert and her commitment to fostering innovation in environmental science. 🌟🌍

📚 Top Noted Publications

Aida has published her research in high-impact, peer-reviewed journals in 2025, showcasing her contributions to environmental chemistry and electrochemical water treatment methods:

1. Zaabtia, A., Ba, M., Ben Amara, M., & Ammar, S. (2025)

Title: Application of a Box–Behnken design to the optimization of margin processing conditions by the electro-Fenton process on different anodes using solar energy
Journal: Journal of Power Sources, Volume 635, Article 236532
🔗 DOI: 10.1016/j.jpowsour.2025.236532
Citations: 7 (as of May 2025)

Summary:
This study explores the use of solar-powered electro-Fenton (EF) technology for wastewater treatment, specifically addressing the degradation of “margin” waste—a challenging by-product from olive oil production. The research employed a Box–Behnken design, a response surface methodology, to optimize operational parameters such as pH, reaction time, and current intensity across different anode materials. Key findings include:

  • Enhanced degradation efficiency when solar energy was coupled with EF.

  • Comparative performance of anode materials like graphite, stainless steel, and boron-doped diamond (BDD).

  • Identified optimal operational conditions leading to maximum COD (Chemical Oxygen Demand) removal.

Significance:
The paper demonstrates a sustainable approach to industrial wastewater treatment using renewable energy and advanced electrochemical techniques, contributing to the green chemistry and waste valorization fields.

2. Zaabtia, A., Ba, M., & Ammar, S. (2025)

Title: Treatment of olive mill wastewater by coagulation–flocculation and electro-Fenton processes: application of the experimental design methodology
Journal: Journal of Applied Electrochemistry, Pages 1–17
🔗 DOI: 10.1007/s10800-025-02308-y
Citations: 5 (as of May 2025)

Summary:
This research presents a hybrid method combining coagulation–flocculation (CF) and electro-Fenton processes to treat olive mill wastewater, a highly polluted industrial effluent rich in polyphenols and organic matter. Using statistical experimental design, the authors optimized treatment parameters such as coagulant dose, pH, and electrolysis time. Main outcomes:

  • The CF pre-treatment significantly improved the efficiency of the subsequent EF step.

  • The hybrid process achieved high removal rates of COD, turbidity, and total phenols.

  • Emphasized cost-effectiveness and scalability of the treatment method.

Significance:
This article contributes a novel treatment protocol for a waste stream prevalent in Mediterranean regions, reinforcing the viability of integrated physicochemical and electrochemical processes for complex wastewater management.

Conclusion

Aida Zaabtia is a high-potential early-career researcher with a focused research trajectory in environmental chemistry and water treatment. Her publication record, technical competence, and active participation in scientific forums demonstrate that she is a strong candidate for the Best Researcher Award, particularly in categories for young researchers, PhD students, or emerging leaders in environmental science.

Xujun Tian | Education and Lingustics | Best Researcher Award

Published on by Molecular Biologist

Dr. Xujun Tian | Education and Lingustics | Best Researcher Award 

Associate Professor, at Shanghai Lixin University of Accounting and Finance, China.

Dr. Xujun (Alan) Tian 🇨🇳 is a distinguished associate professor at the School of Foreign Languages, Shanghai Lixin University of Accounting and Finance. With a profound academic journey rooted in translation studies, he has contributed significantly to the fields of corpus-based translation, discourse analysis, and image studies. Holding a Ph.D. in Foreign Languages and Literature from Shanghai Jiao Tong University, an M.A. (Distinction) in Translation with Language Technology from Swansea University, UK, and a B.A. in English from Xiangtan University, Dr. Tian merges Western linguistic technology with Chinese rhetorical tradition. Over the last two decades, he has held academic roles across China and the U.S., including the University of Texas at Dallas. 📚 His expertise is recognized in over 20 journal articles, key research grants, and membership in the Baker Center for Translation. His corpus-driven work provides innovative insights into China’s evolving global narrative. 🌏

Professional Profile

Scopus

ORCID

🎓 Education

Dr. Tian’s academic background reflects a balance of Eastern depth and Western innovation. He earned his Ph.D. in Foreign Languages and Literature from Shanghai Jiao Tong University (2016–2020), one of China’s leading research institutions, where his dissertation focused on the evolution of China’s diplomatic image. Prior to that, he completed a Master’s degree with Distinction in Translation with Language Technology at Swansea University, UK (2005–2007), gaining hands-on experience with corpus tools and CAT systems. His foundational training in English Language and Literature began at Xiangtan University (1996–2000), where he cultivated a deep appreciation for comparative linguistics and intercultural communication. 🏫 Dr. Tian’s interdisciplinary education combines traditional literature, linguistic analytics, and digital translation technologies—equipping him to lead the future of corpus-based translation studies. 🧠

💼 Experience

Dr. Tian has held diverse academic and administrative positions since 2000. He is currently an Associate Professor at Shanghai Lixin University of Accounting and Finance (2023–present), where he mentors MA students in translation and discourse studies. Prior roles include Associate Professor at China Three Gorges University (2021–2023) and Lecturer/Associate Professor from 2011 to 2016. He also served as Program Coordinator and Assistant to the Chinese Director at the University of Texas at Dallas (2009–2011), contributing to cross-cultural academic programming at the Confucius Institute. 📘 Dr. Tian began his career at China Three Gorges University (2000–2005), where he returned multiple times, reflecting his strong institutional ties. His experience bridges domestic and international academia, making him a global scholar with an emphasis on applied translation and discourse research. 🌐

🔬 Research Interest

Dr. Tian’s research lies at the intersection of corpus linguistics, translation studies, and image construction. His work focuses on corpus-based translation studies, with a special emphasis on how discourse and modal verbs shape national narratives in translated texts. 🧾 He is deeply engaged in image studies, analyzing how China’s national identity is constructed across multilingual corpora. His recent projects include comparative analyses of diplomatic discourse across Chinese, English, French, Russian, and Arabic, funded by national and provincial agencies. He also explores Computer-Assisted Translation (CAT) tools and the development of terminology management curricula. By blending technology with theory, Dr. Tian pushes forward translator training models in the digital era. His work on the Chinese-English translation of government reports stands as a model for high-impact corpus-informed policy discourse research. 📈

🏆 Awards

🎖️ In 2013, Dr. Tian was honored with the “Excellent Staff” award from China Three Gorges University, recognizing his outstanding contribution to teaching, research, and service. This early accolade laid the foundation for his future impact in both academia and public scholarship. Additionally, his research projects have received prestigious national and provincial funding, including grants from the Ministry of Science and Technology of China and the Hubei Department of Education. His recognized excellence in translator training, corpus-based analysis, and the internationalization of China’s image reflects a career built on rigorous scholarship and innovation. He is also an affiliate member of the Baker Center for Translation and Intercultural Studies, enhancing global dialogues in translation. 🏅

📚Top Noted Publications

Dr. Tian has authored 23 publications, including peer-reviewed journal articles, book chapters, standards, and translations. His work has appeared in Frontiers in Psychology, PLOS ONE, Heliyon, Corpora, and top Chinese journals like Foreign Languages in China and Shanghai Journal of Translators. His 2025 article on modal verbs in Chinese government reports (👉 PLOS ONE, 2025) explores translator mediation in political discourse. Another notable study, “Personalized Translator Training in the Era of Digital Intelligence” (👉 Heliyon, 2024), discusses AI’s role in translation pedagogy. His research has been cited in multiple cross-linguistic studies, signaling international relevance. 🧾 His work offers tools and frameworks for scholars, educators, and policymakers seeking to understand how translation and discourse reflect and shape national narratives.

📎 Selected Publications with Hyperlinks, Year, Journal, and Citations

1. Translators as Mediators… Modal Verbs in Government Reports

  • Year: 2025

  • Journal: PLOS ONE

  • Citations: 4

  • Focus: Explores the mediating role of translators in rendering modal verbs in official government documents, likely using corpus-based methodology.

  • Relevance: Highlights the nuances of modality in translation and its potential impact on diplomatic or political communication.

2. Personalized Translator Training in the Era of Digital Intelligence

  • Year: 2024

  • Journal: Heliyon

  • Citations: 7

  • Focus: Discusses how digital tools and AI can tailor translator education, possibly advocating adaptive or intelligent tutoring systems for MTI (Master of Translation and Interpreting) students.

  • Relevance: Applies digital intelligence to enhance translation pedagogy.

3. Translation Studies Based on a Multilingual Corpus

  • Year: 2023

  • Journal: Journal of Beijing International Studies University

  • Citations: 3

  • Focus: Uses a multilingual corpus to inform translation theory or practice, likely offering cross-linguistic insights.

  • Relevance: Bridges theoretical translation studies with empirical multilingual data.

4. Corpus-Based Analysis of China’s Diplomatic Stance

  • Year: 2022

  • Journal: Frontiers in Psychology

  • Citations: 12

  • Focus: Uses corpus linguistics to examine linguistic strategies that reflect China’s diplomatic positioning.

  • Relevance: Intersects translation, corpus linguistics, and international relations.

5. A Corpus-Based Study of Modal Verbs in Government Reports

  • Year: 2022

  • Journal: Shanghai Journal of Translators

  • Citations: 6

  • Focus: Analyzes the use of modal verbs in official reports, probably the Chinese-English translation context.

  • Relevance: Complements the 2025 PLOS ONE article, emphasizing modality and pragmatics.

6. Review: Corpus-based Translation in Chinese Contexts

  • Year: 2022

  • Journal: Corpora

  • Citations: 2

  • Focus: A review article evaluating corpus-based translation research in China, perhaps with a critical or meta-analytic lens.

  • Relevance: Serves as a literature synthesis and reflection on the state of the field.

7. Corpus-based Study on China’s Diplomatic Image (1949–2018)

  • Year: 2020

  • Type: Dissertation

  • Citations: 5

  • Focus: Longitudinal study analyzing China’s diplomatic portrayal over nearly 70 years using corpus methods.

  • Relevance: Historical scope makes it foundational for later works.

8. MTI Education under Language Intelligence

  • Year: 2020

  • Journal: Foreign Language World

  • Citations: 8

  • Focus: Addresses the integration of AI and digital tech in professional translator training programs (MTI).

  • Relevance: Educational innovation in the context of language tech.

9. Corpus-Based Study on Chinese Diplomatic Keywords

  • Year: 2020

  • Journal: Foreign Languages in China

  • Citations: 9

  • Focus: Identifies and analyzes key terms in Chinese diplomacy through corpus techniques.

  • Relevance: Valuable for discourse analysis and diplomatic communication.

10. A Corpus-based Study of China’s Diplomatic Images in Translation

  • Year: 2018

  • Journal: Foreign Languages in China

  • Citations: 11

  • Focus: Investigates how translation affects international perceptions of China’s diplomacy.

  • Relevance: Early work connecting corpus linguistics with image construction.

Conclusion

Dr. Xujun (Alan) Tian is a highly qualified and compelling candidate for the Best Researcher Award. His interdisciplinary expertise, robust publication record, and funded research projects reflect a scholar of strong academic merit and long-term contribution to translation studies, particularly in corpus-based methodologies. While there is room to enhance global recognition and interdisciplinary impact, his current profile already demonstrates excellence in research, innovation, and academic service.

Abdullah Karaer | Molecular Biology | Best Researcher Award

Published on by Molecular Biologist

Prof. Dr. Abdullah Karaer | Molecular Biology | Best Researcher Award 

Researcher, at Inonu University School of Medicine, Turkey.

Prof. Dr. Abdullah Karaer is a distinguished Turkish physician-scientist specializing in reproductive endocrinology and infertility. Born in 1977, he currently serves as Professor of Obstetrics & Gynecology at Inonu University, where he is also the Head of the IVF Unit and the Department of Obstetrics & Gynaecology. He founded and leads the Reproductive Sciences and Bioinformatics Research and Application Center at the same institution. With over two decades of experience, Dr. Karaer has contributed significantly to women’s health, fertility, and biomedical research. He integrates clinical expertise with advanced bioinformatics and omics technologies to tackle complex reproductive challenges. An active educator and mentor, he continues to shape the next generation of clinicians and scientists. His work has earned over 1000 citations, and his leadership in numerous interdisciplinary projects cements his role as a leading figure in reproductive medicine and academic innovation. 🌐🧪

Professional Profile

Scopus

ORCID

Google Scholar

🎓 Education 

Prof. Dr. Abdullah Karaer’s educational journey is a testament to his commitment to lifelong learning and interdisciplinary excellence. He earned his M.D. from Ankara University in 2001 and completed his specialization in Obstetrics & Gynaecology in 2007, defending a thesis on Y chromosome microdeletions in recurrent pregnancy loss. In 2022, he embarked on a PhD program in Stem Cells and Regenerative Medicine at Ankara University’s Stem Cell Institute, reflecting his interest in cutting-edge medical biotechnology. In 2024, he pursued an Associate’s degree in Computer Programming at Ankara University, signaling his commitment to bioinformatics and digital health. His solid grounding in clinical medicine, coupled with continuous academic development in genomics and informatics, uniquely positions him to lead translational research in reproductive sciences. 🧠📚💻

💼 Experience 

Dr. Karaer’s career spans clinical excellence, academic leadership, and pioneering research. Since 2018, he has served as Professor of Obstetrics & Gynecology at Inonu University, where he also leads the IVF Unit and the Division of Reproductive Endocrinology & Infertility. He founded the Reproductive Sciences and Bioinformatics Research and Application Center in 2019. Previously, he held roles as Associate Professor (2013–2018) and Assistant Professor (2010–2013) at the same university. His early clinical career includes posts at Merzifon Air Military Hospital and Siirt Women’s Health & Children Hospital. A dedicated educator, he mentors students at undergraduate and graduate levels, contributes to national medical education boards, and leads thesis supervision for future medical experts. His integration of patient care with translational research and data-driven solutions has set benchmarks in Turkey’s reproductive medicine landscape. 🏥📈👨‍🏫

🔬 Research Interest 

Prof. Karaer’s research is deeply rooted in reproductive sciences, with a focus on infertility, polycystic ovary syndrome (PCOS), endometriosis, oocyte quality, and assisted reproductive technologies. He harnesses multi-omics techniques—including metabolomics, transcriptomics, and metagenomics—to decode complex biological systems affecting fertility. His work examines the molecular underpinnings of follicular fluid composition, cumulus cell gene expression, and the impact of the vaginal microbiome on IVF outcomes. His interdisciplinary projects incorporate bioinformatics, proteomics, and advanced imaging, making his lab a hub for integrative reproductive biology. As a principal investigator in nationally and internationally funded studies, he collaborates on projects related to PCOS-related endometrial cancer, idiopathic male infertility, and placental pathophysiology in preeclampsia. Dr. Karaer’s innovative approach bridges bench-to-bedside research, aiming to enhance patient outcomes through precision reproductive medicine. 🧫🧬🧠

🏆 Awards 

Prof. Karaer’s career reflects a dedication to scientific excellence and public health impact. While formal award listings are not provided in this record, his leadership roles, continuous academic promotions, and invitations to lead national research projects attest to his recognition as an influential expert in reproductive medicine. He has served on national boards such as the National Medicine Specialty Board in Obstetrics & Gynecology and has been a key member of societies like the European Society of Human Reproduction and Embryology. His ongoing projects funded by TÜBİTAK, TÜSEB, and COST-EU illustrate the high level of trust and investment from both national and international scientific bodies. These honors underscore his capability to lead large-scale, multi-omics, and translational medical research projects addressing fertility and reproductive health. 🏅🌍📖

📚 Top Noted Publications

Dr. Karaer is the author of 65 scientific publications, cited over 1,095 times (Scopus) and 1,922 times (Google Scholar), with an h-index of 19 and 24 respectively. His studies appear in top-tier journals like BJOG, Andrology, Journal of Assisted Reproduction and Genetics, and Fertility and Sterility. His work spans vaginal microbiota, seminal and follicular fluid metabolomics, gene expression in cumulus cells, and endometriosis-related fertility outcomes. Notable publications include:

1. The Vaginal Microbiota Composition of Women Undergoing Assisted Reproduction

  • Journal: BJOG: An International Journal of Obstetrics & Gynaecology

  • Publication Year: 2021

  • Study Type: Prospective cohort study

  • Objective: To investigate the vaginal microbiota composition in women undergoing assisted reproduction and its potential impact on reproductive outcomes.

  • Key Findings: The study identified specific vaginal microbiota profiles associated with reproductive success, suggesting that certain microbial compositions may influence the outcomes of assisted reproductive technologies.

  • Link: PubMed Abstract

2. Metabolomics Analysis of Seminal Plasma in Patients with Idiopathic Oligoasthenoteratozoospermia Using High-Resolution NMR Spectroscopy

  • Journal: Andrology

  • Publication Year: 2020

  • Authors: A. Mumcu, A. Karaer, B. Dogan, G. Tuncay

  • Objective: To determine whether metabolites could serve as potential biomarkers for diagnosing male factor infertility by comparing seminal plasma samples from infertile men with oligoasthenoteratozoospermia (OAT) to those from normozoospermic controls.

  • Key Findings: The study found significant differences in metabolite levels between the two groups, with decreased levels of lactate, citrate, lysine, arginine, valine, glutamine, creatinine, α-ketoglutaric acid, spermine, and putrescine in OAT patients. Tyrosine levels were increased. The PLS-DA model achieved 89.29% sensitivity and 93.55% specificity in distinguishing between the groups.

  • Link: Wiley Online LibraryWiley Online Library

3. The Effect of Seminal Plasma Cadmium and Lead Levels on Semen Parameters in Male Subjects of Infertile Couples: A Prospective Cohort Study

  • Journal: Journal of Obstetrics and Gynaecology

  • Publication Year: 2020

  • Authors: Gorkem Tuncay, Abdullah Karaer, Emrullah Tanrikut, Onur Ozgul

  • Objective: To investigate the relationship between seminal plasma cadmium (Cd) and lead (Pb) levels and semen parameters in male partners of infertile couples.

  • Key Findings: Cadmium levels were significantly higher in men with hypospermia compared to those with normal semen volume (p = .049). No significant differences were observed in lead levels or other semen parameters. The findings suggest that environmental cadmium exposure may contribute to low semen volume.

  • Link: Taylor & Francis OnlineTaylor & Francis Online+1PubMed+1

4. Follicular Fluid Metabolomics in Maternal Aging

  • Journal: Journal of Assisted Reproduction and Genetics (JARG)

  • Publication Year: 2020

  • Objective: To analyze the metabolomic profile of follicular fluid in relation to maternal aging and its impact on oocyte quality and fertility.

  • Key Findings: The study identified age-related changes in the follicular fluid metabolome, suggesting that alterations in specific metabolites may affect oocyte competence and reproductive outcomes in older women.

  • Link: PubMed Abstract

5. Microarray Analysis in Endometriosis

  • Journal: Journal of Endometriosis and Pelvic Pain Disorders (JEPPD)

  • Publication Year: 2020

  • Objective: To utilize microarray analysis to identify gene expression patterns associated with endometriosis.

  • Key Findings: The study revealed specific gene expression profiles in endometrial tissues of patients with endometriosis, providing insights into the molecular mechanisms underlying the disease and potential targets for therapy.

  • Link: PubMed Abstract

Conclusion

Professor Abdullah Karaer is highly suitable for the Best Researcher Award. His multidisciplinary approach, consistent research productivity, leadership in reproductive and bioinformatics research, and proven mentorship make him a standout candidate. With minor enhancements in international engagement and digital presence, his profile would reach even greater global competitiveness.

Rongbin Li | Cancer Biology | Best Researcher Award

Published on by Molecular Biologist

Dr. Rongbin Li | Cancer Biology | Best Researcher Award 

Doctorate, at Peking University, China.

Dr. Rongbin Li is a dynamic and emerging immunologist affiliated with the Department of Immunology, School of Basic Medical Sciences, and NHC Key Laboratory of Medical Immunology, Peking University, Beijing, China. He also contributes significantly to the Peking University Center for Human Disease Genomics. With a robust academic background in clinical and immunological sciences, Dr. Li’s research is focused on colitis-associated carcinogenesis and the molecular pathways that contribute to inflammatory bowel disease (IBD) and colorectal cancer. His recent milestone includes a first-author publication in the high-impact journal Cellular and Molecular Gastroenterology and Hepatology, coupled with a patent application for CMTM3 as a therapeutic target. Dr. Li has also presented his research at national congresses, underlining his capability in both lab innovation and scientific communication. His dedication to unraveling immune mechanisms promises meaningful breakthroughs in medical immunotherapy. 🌟

Professional Profile

ORCID

🎓 Education

Dr. Rongbin Li pursued his Ph.D. in Immunology at the prestigious Peking University from 2019 to 2024, focusing on medical immunology and disease genomics. His academic journey was marked by exceptional research, culminating in a first-author publication and a nationally recognized patent. Prior to this, he earned a B.Med. in Clinical Medicine from Hebei University of Engineering (2014–2019), where he was trained in clinical diagnostics, pathophysiology, and foundational immunology. His educational progression reflects a strong foundation in both theoretical knowledge and experimental methodologies. Through rigorous coursework, extensive lab work, and early exposure to clinical sciences, Dr. Li has built a dual competence in clinical medicine and molecular immunology, making him uniquely positioned to bridge the gap between bedside and bench. His multidisciplinary academic background underpins his innovative contributions to immunotherapy and cancer research. 🎓🧪

💼 Experience 

Dr. Li’s professional experience is deeply intertwined with cutting-edge immunological research at Peking University. During his doctoral tenure, he was entrusted with a National Natural Science Foundation of China (NSFC) funded project where he led experimental design, data analysis, and manuscript preparation. In collaboration with Peking University Third Hospital, he played a pivotal role in uncovering the mechanism of CMTM3 in aggravating colitis and promoting carcinogenesis, leading to a patent application. His responsibilities included conceptualization, methodology design, formal analysis, and software development, demonstrating expertise in both wet lab and computational environments. He also delivered an oral presentation at the 15th National Congress of Immunology (2023), showcasing his communication skills and subject mastery. His current research on therapeutic targets for IBD reflects a strong commitment to translational medicine. With a blend of lab skills, analytical capabilities, and cross-institutional teamwork, Dr. Li exemplifies the modern biomedical researcher. 🔬👨‍🔬

🔍 Research Interest 

Dr. Rongbin Li’s core research interest revolves around colitis-associated carcinogenesis, with a focus on the immunological and molecular interactions that promote inflammatory bowel disease (IBD) and colorectal cancer. 🧫 His primary interest lies in deciphering the role of CMTM3, a novel therapeutic target that stabilizes CLTC and disrupts VE-cadherin regulation via clathrin-mediated pathways. His ongoing work investigates how immune and endothelial interactions exacerbate inflammatory responses and facilitate tumorigenesis. He also explores the mechanistic crosstalk between inflammation and epithelial-mesenchymal transition (EMT), with the broader goal of developing CMTM3-targeted biologics or small molecules. His interdisciplinary approach combines molecular immunology, cancer biology, and vascular biology, aimed at discovering actionable targets for precision medicine. By merging bioinformatics, cellular assays, and in vivo models, Dr. Li aspires to translate fundamental immunological discoveries into clinically viable therapies, particularly for patients suffering from chronic inflammation-related cancers. 🌐🧠

🏆 Awards 

Dr. Rongbin Li’s promising contributions to immunology have garnered notable recognition. His recent work funded by the National Natural Science Foundation of China (NSFC) signifies his capability to lead and innovate in high-stakes research environments. 🧪 His first-author article in Cellular and Molecular Gastroenterology and Hepatology stands as a testament to his scholarly excellence, originality, and scientific rigor. In 2023, he was selected for an oral presentation at the 15th National Congress of Immunology, one of the most prestigious scientific forums in China. Additionally, his innovative findings led to a patent application titled “CMTM3 as a therapeutic target for IBD and colorectal cancer” (Appl. No: 2025104021503), demonstrating real-world impact and translational potential. These achievements position him as a strong candidate for the Best Researcher Award, celebrating his impactful early-career journey, commitment to scientific advancement, and potential for future breakthroughs in immunology and cancer therapy. 🏅

📚 Top Noted Publications 

Dr. Rongbin Li’s scholarly work has made a significant impact in the field of immunology. His first-author research article, published in the reputable journal Cellular and Molecular Gastroenterology and Hepatology (2025), elucidates the critical role of CMTM3 in colitis-associated carcinogenesis. The study reveals how CMTM3 stabilizes CLTC and contributes to vascular endothelial dysfunction, advancing our understanding of inflammation-driven cancer mechanisms.

Key Findings

This research identifies CMTM3 (CKLF-like MARVEL transmembrane domain-containing 3) as a significant contributor to colitis-associated colorectal cancer (CAC). The study elucidates that CMTM3 stabilizes CLTC (clathrin heavy chain), enhancing clathrin-mediated endocytosis. This process leads to the internalization and degradation of VE-Cadherin, a crucial adhesion molecule in vascular endothelial cells. The loss of VE-Cadherin disrupts endothelial integrity, increasing vascular permeability, which exacerbates colitis and fosters a pro-inflammatory environment conducive to carcinogenesis.​BioMed Central

Citation Information

As of the latest database update, this article has been cited by two other publications, indicating its emerging influence in the field of gastrointestinal oncology.​

Related Research

Previous studies have explored the role of CMTM3 in various cancers. For instance, research has shown that CMTM3 can mediate angiogenesis by regulating the cell surface availability of VE-Cadherin in endothelial adherens junctions . These findings align with the current study’s observations on CMTM3’s impact on endothelial function and its potential role in cancer progression.

Conclusion

Dr. Rongbin Li shows exceptional promise as a medical immunologist with impactful research on colitis-associated cancer, underpinned by innovation (a therapeutic patent), prestigious institutional affiliation, and peer-reviewed publication. While citation metrics and broader scholarly visibility are still developing, the quality, novelty, and translational potential of his work make him well-suited for the Best Researcher Award.

Weiwei Fu | Molecular Biology | Best Researcher Award

Published on by Molecular Biologist

Dr. Weiwei Fu | Molecular Biology | Best Researcher Award 

Research assistant professor, at Peking University Third Hospital, China.

Dr. Fu Weiwei is an accomplished medical scientist specializing in gastroenterology and immunology. She currently serves as an Assistant Research Professor and Laboratory Director at the Gastroenterology Department, Peking University Third Hospital, where she leads research at the Beijing Key Laboratory. Dr. Fu earned her Ph.D. in Immunology from Peking University Health Science Center and has a strong foundation in traditional medicine, holding a Bachelor of Medicine from Shandong University. With more than a decade of experience in translational medical research, her work bridges cutting-edge immunological discoveries and practical clinical applications. Her focus lies in immune microenvironment dynamics, gastrointestinal tumor evolution, and the integration of traditional Chinese medicine for digestive disease therapies. She has delivered several high-profile international presentations and has published widely in leading scientific journals. Her contributions have significantly advanced the field of digestive immunology.

Professional Profile

Scopus

ORCID

🎓 Education

Dr. Fu’s academic journey began with a 5-year Bachelor of Medicine program at Shandong University of Traditional Chinese Medicine (2002–2007), where she laid a solid foundation in both conventional and traditional healthcare practices. Her early exposure to integrative medicine inspired a unique perspective on digestive health and immune response. Motivated by scientific rigor, she enrolled in the Combined Master’s and Ph.D. Program in Immunology (2008–2013) at Peking University Health Science Center, mentored by Prof. Wenling Han. This elite program sharpened her skills in molecular biology, immunopathology, and clinical translational research. Throughout her doctoral years, she focused on the host immune responses in cancer, particularly those related to gastric inflammation and tumorigenesis. This diverse academic training enables her to merge modern biomedical technologies with traditional insights, giving her an edge in the multidisciplinary field of digestive immunology.

🧪 Experience

Dr. Fu brings a wealth of research and clinical experience to her current position at the Gastroenterology Department, Peking University Third Hospital (2019–present), where she directs the Beijing Key Laboratory. As an Assistant Research Professor, she leads a team focusing on translational immunology in gastrointestinal diseases. Before this, she completed a prestigious postdoctoral fellowship (2013–2019) at the Tsinghua University Institute of Immunology under Prof. Chen Dong, an Academician of the Chinese Academy of Sciences. During this time, she worked on T-cell signaling, immune checkpoints, and the role of lymphoid cells in cancer. Her lab currently integrates clinical cohort data with multi-omics techniques to explore disease mechanisms. She is also instrumental in mentoring junior researchers and clinicians. Her work bridges laboratory immunology with bedside applications, ensuring scientific advancements are translated into improved diagnosis and therapy for patients.

🔬 Research Interests

Dr. Fu’s research centers on the immune microenvironment in gastrointestinal tumors and digestive tract diseases, such as gastric cancer and inflammatory bowel disease. She applies multi-omics technologies—including single-cell RNA sequencing, proteomics, and microbiome analysis—to decipher host-pathogen interactions and immune cell dynamics during disease evolution. A key aspect of her research is understanding how Helicobacter pylori infection initiates gastric lesions, tumor progression, and immune escape. She also investigates traditional Chinese medicine-based therapies, exploring their role in cancer prevention and immune modulation. Another focal point is early screening and biomarker discovery for precancerous lesions through clinical cohort studies. By integrating high-throughput data with clinical insights, her work aims to improve patient stratification and individualized treatments. Her interdisciplinary approach bridges immunology, oncology, and traditional medicine, placing her at the forefront of gastrointestinal research in China and beyond.

🏆 Awards

Dr. Fu’s scientific excellence has been consistently recognized. She won the Outstanding Paper Award at the 2023 Chinese Medical Association’s National Conference on Digestive Diseases (CGC 2023) for her oral presentation on immune profiling during colorectal cancer progression. Her continuous contributions to clinical immunology, translational oncology, and molecular diagnostics have earned her accolades from both national and international platforms. Her selection as an oral presenter at leading conferences—such as DDW 2024 in Washington, D.C., and UEGW 2023 in Copenhagen—speaks to her international recognition. She has also received patent grants for innovations in inflammation and cancer therapy, reflecting her drive for practical applications. As a dedicated researcher, educator, and innovator, Dr. Fu stands out as a top candidate for award nominations in the fields of biomedical research and clinical translational science.

📚 Top Noted Publications

Dr. Fu has authored and co-authored numerous impactful papers in top-tier journals (JCR Q1–Q3), often as first or corresponding author. Below are select publications with hyperlink.

2025

  1. Luteolin Improves Precancerous Gastric Mucosa by Binding STAT3
    International Journal of Biological Sciences (Q1, IF 8.1)
    📌 Co-Corresponding Author
    🧪 Original Research

  2. CMTM3 Regulates Colitis-Associated Cancer Progression
    Cellular and Molecular Gastroenterology and Hepatology (CMGH) (Q1, IF 7.1)
    📌 Co-Corresponding Author
    🧬 Original Research

  3. Cmtm4 Deficiency Exacerbates H. pylori-Induced Gastric Carcinogenesis
    Pathology International (Q2, IF 2.5)
    📌 Co-Corresponding Author
    🦠 Original Research

  4. The Host Immune Response Landscape in Gastric Cancer Development
    Clinical and Experimental Immunology (Q2, IF 3.4)
    📌 First Author
    🧫 Original Research

2024

  1. Neutrophil Heterogeneity in Hepatocellular Carcinoma and Tumor Immunity
    Cancer Medicine (Q2, IF 2.9)
    📌 Co-First Author
    🔬 Original Research

  2. Oxidative Balance in Diet and Sleep Patterns: A Metabolic Interaction
    Frontiers in Nutrition (Q2, IF 4.0)
    📌 Co-First Author
    🍽 Original Research

  3. CMTM4 Facilitates Gastric Cancer Metastasis via EMT Modulation
    Journal of Gastrointestinal Oncology (Q3, IF 2.0)
    📌 Co-First Author
    🧠 Original Research

  4. Cmtm4 Shapes Colitis Outcomes via Microbial Dysbiosis and Mucosal Immunity
    Journal of Genetics and Genomics (Q1, IF 6.6)
    📌 Co-Corresponding Author
    🧪 Original Research

  5. Serum Proteomics-Based Biomarkers of Precancerous Gastric Lesions
    Frontiers in Molecular Biosciences (Q2, IF 3.9)
    📌 Co-Corresponding Author
    🔍 Original Research

  6. Treg Subsets Orchestrate Tumor Microenvironment in Colorectal Cancer
    Frontiers in Immunology (Q1, IF 5.7)
    📌 Co-First & Corresponding Author
    🧫 Original Research

2023

  1. Helicobacter pylori and Inflammasome Activation in Gastric Pathogenesis (Review)
    Helicobacter (Q2, IF 4.3)
    📌 Co-Corresponding Author
    🧯 Review Article

2022

  • Lymphocyte Profile Alterations in Precancerous Gastric Lesions
    Journal of Leukocyte Biology (Q2, IF 5.5)
    📌 First Author
    🧬 Original Research

  • B7 Family Molecules and Immune Evasion in H. pylori Infection (Review)
    Helicobacter (Q2, IF 4.4)
    📌 Co-Corresponding Author
    🧫 Review Article

Conclusion

Dr. FU Weiwei demonstrates an exceptional and well-rounded profile as a medical researcher with significant contributions to immunology and gastroenterology, supported by prestigious academic training, a robust scientific publication record, impactful patents, and strong conference presence. These achievements, particularly in translational cancer immunology, make Dr. Fu highly suitable for the Best Researcher Award.

ChongChao Yang | Molecular Pharmacology | Best Researcher Award

Published on by Molecular Biologist

Dr. ChongChao Yang | Molecular Pharmacology | Best Researcher Award

Dr. ChongChao Yang at Nanjing Medical University, China.

Dr. Chong-chao Yang is currently pursuing his Ph.D. in Ophthalmology at Nanjing Medical University, China. 📍 With a keen focus on ocular neovascularization, Dr. Yang’s work dives deep into the mechanisms and therapeutic interventions for retinal diseases, particularly those associated with diabetes. His scientific rigor and precision are reflected in several publications in reputed SCI journals. 🔬 Among his noted achievements is the receipt of the prestigious National Scholarship for Doctoral Students, which highlights his academic excellence. Dr. Yang not only conceptualizes innovative research frameworks but also leads experiments, analyses, and manuscript writing. 🧪 His interdisciplinary approach combines molecular pharmacology with natural compound therapeutics, particularly studying the anti-angiogenic effects of sclareol. Known for his dedication, Dr. Yang is committed to advancing retinal research and translating scientific findings into therapeutic strategies that can impact global ophthalmic care. 🌏

Professional Profile

Scopus

ORCID

🎓 Education

Dr. Chong-chao Yang began his academic journey with a strong foundation in medical sciences and later advanced into ophthalmic research. He is currently a Ph.D. candidate in Ophthalmology at Nanjing Medical University, one of China’s premier medical institutions. 🏫 His education centers around a combination of biomedical sciences, ophthalmic pathology, and molecular pharmacology, enabling a deep understanding of the visual system at both the anatomical and biochemical levels. He has built a solid theoretical and practical base in multi-omics, angiogenesis, and drug metabolism, all critical for his work in retinal neovascularization. 📖 With a methodical academic pathway and a thirst for innovation, Dr. Yang has consistently ranked among the top of his cohort and earned notable academic honors. His current Ph.D. research not only reflects academic excellence but also responds to urgent medical challenges associated with diabetic retinopathy and age-related eye disorders. 👁️‍🗨️

🧪 Experience

Chong-chao Yang has acquired significant experience in translational ophthalmic research, with a focus on angiogenesis and retinal pharmacokinetics. His academic and laboratory training has equipped him with comprehensive skills in experimental design, in vivo/in vitro assays, and bioinformatics-based molecular analysis. 🔍 During his Ph.D., he led an innovative project exploring the anti-angiogenic effects of sclareol, a plant-derived natural compound, using multi-omics platforms and pharmacokinetic profiling. 💊 Dr. Yang’s responsibilities extended from designing research protocols to data interpretation and manuscript preparation. He actively collaborated with clinicians and fellow researchers, reflecting his ability to merge experimental science with clinical relevance. 🧫 His published meta-analysis on retinal microvasculature in amblyopic eyes and work on metabolite links with diabetic retinopathy further showcase his diverse research capabilities. His passion, diligence, and scientific vision make him a promising future leader in ocular pharmacology. 🌱

🔬 Research Interests

Dr. Yang’s research interests lie at the intersection of ocular neovascularization, angiogenesis, pharmacokinetics, and natural product pharmacology. His primary focus is to uncover the molecular mechanisms driving pathological blood vessel formation in the retina and to evaluate natural compounds, such as sclareol, as potential anti-angiogenic agents. 🌿 He employs a combination of Mendelian randomization, multi-omics techniques, and in vivo pharmacokinetic assays to understand how these agents work at cellular and systemic levels. His studies have explored novel insights into retinal microvascular remodeling, aiming to translate preclinical findings into therapeutic applications for diabetic retinopathy, retinopathy of prematurity, and age-related macular degeneration. 🧠 In addition, he is increasingly interested in how metabolomic profiles relate to retinal disorders, which may guide personalized medicine in ophthalmology. Through cutting-edge research methodologies and interdisciplinary collaboration, Dr. Yang seeks to bridge molecular discoveries with real-world clinical solutions. 💡

🏆 Awards

Dr. Chong-chao Yang has been recognized for his academic brilliance and research excellence throughout his Ph.D. journey. His most distinguished honor is the National Scholarship for Doctoral Students, a prestigious award granted to top-performing students across China. 🎓 This award reflects his outstanding contributions to scientific research and academic excellence. Furthermore, Dr. Yang has consistently received departmental recognition for his publication output, research innovation, and scientific integrity. His participation in international journals such as Frontiers in Endocrinology and Ophthalmic Research has amplified his reputation as a young and promising researcher. 🏅 He has also been nominated for early-career research awards, with several of his peers and mentors praising his original work in ocular pharmacology and retinal biology. As he continues to contribute to the field of ophthalmology, Dr. Yang is a strong contender for awards in both national and international scientific forums. 🌐

📚Top Noted Publications

1. Yang, C.-C., Jiang, Q., & Xue, J.-S. (2024).

Title: Comprehensive multi-omics and pharmacokinetics reveal sclareol’s role in inhibiting ocular neovascularization
Journal: Phytomedicine
Link: ScienceDirect (exact link not provided)
Cited by: 0

Summary:
This study investigates the anti-angiogenic effects of sclareol, a plant-derived diterpene alcohol, using a multi-omics approach (including transcriptomics, proteomics, and metabolomics) combined with pharmacokinetic analysis. The authors identify key molecular pathways influenced by sclareol, especially those linked to VEGF signaling and oxidative stress, which are implicated in ocular neovascularization—a hallmark of diseases such as age-related macular degeneration and diabetic retinopathy. The findings demonstrate sclareol’s ability to inhibit pathological blood vessel formation in the eye, suggesting its potential as a therapeutic agent in ophthalmology.

2. Yang, C.-C., et al. (2023).

Title: Causal relationships between blood metabolites and diabetic retinopathy: a two-sample Mendelian randomization study
Journal: Frontiers in Endocrinology, 14, 1213434
Link: Frontiers (exact link not provided)
Cited by: 3

Summary:
Using two-sample Mendelian randomization (MR), this paper explores the causal links between circulating blood metabolites and diabetic retinopathy (DR). Data from large-scale GWAS and metabolomics repositories were analyzed to identify metabolites that are not just associated with DR, but causally implicated. Several metabolites related to lipid metabolism and inflammation were found to significantly increase the risk of DR. The study highlights potential biomarkers and therapeutic targets for early intervention in DR, with implications for precision medicine approaches.

3. Yang, C.-C., et al. (2023).

Title: Analysis of Retinal Microvasculature Features in Amblyopic Eyes: A Meta-Analysis
Journal: Ophthalmic Research, 66(2), 155–162
Link: Karger (exact link not provided)
Cited by: 5

Summary:
This meta-analysis synthesizes data from multiple optical coherence tomography angiography (OCTA) studies to assess retinal microvascular changes in amblyopic eyes. The findings suggest significant reductions in vessel density and perfusion in amblyopic eyes compared to controls, particularly in the superficial vascular plexus. These results offer new insights into the vascular mechanisms underlying amblyopia and suggest that microvascular features may serve as diagnostic or monitoring biomarkers in amblyopia management.

Conclusion

Based on the evidence provided, Chong-chao Yang is a promising early-career researcher with a solid academic foundation, innovative focus, and active contribution to the field of ophthalmology. His clear research trajectory, publication in SCI-indexed journals, and national recognition make him a credible and deserving nominee for the Best Researcher Award, especially in the early career or emerging researcher category.

Deepak Maurya | Molecular | Best Researcher Award

Published on by Molecular Biologist

Assist. Prof. Dr. Deepak Maurya | Molecular | Best Researcher Award 

Assistant Professor, at Department of Mathematics, V.B.S. Purvanchal University, Jaunpur-222001 (U.P.), India.

Dr. Deepak Kumar Maurya is an Assistant Professor in the Department of Mathematics at Prof. Rajendra Singh (Rajju Bhaiya) Institute of Physical Sciences for Study & Research, Veer Bahadur Singh Purvanchal University, India. He completed his Ph.D. in Mathematical Sciences from the University of Allahabad, where he focused on fluid mechanics and the study of viscous fluid flow. With several years of experience in teaching and research, Dr. Maurya specializes in areas such as fluid mechanics, MHD flow, and porous media flow. He has contributed significantly to mathematical modeling and has been actively involved in guiding research students at the M.Sc. and Ph.D. levels. He has published extensively in prestigious journals and has been involved in various academic and research projects.

Professional Profile

Scopus

ORCID

Google Scholar

Education 🎓

Dr. Deepak Kumar Maurya’s academic journey began with a B.Sc. in Physics, Chemistry, and Mathematics from Dr. R.M.L. Avadh University, Ayodhya, in 2014. He continued his academic progression with an M.Sc. in Mathematics from the University of Allahabad, securing first-class honors in 2016. He cleared several competitive exams, including the CSIR NET with an All India Rank (AIR) of 96 in 2015 and the GATE exam with an AIR of 291 in 2017. Dr. Maurya pursued his Ph.D. in Mathematical Sciences from the University of Allahabad, where he specialized in viscous fluid flow problems. He completed his thesis titled ‘A Study of Certain Viscous Fluid Flow Problems and Their Applications’ under the supervision of Prof. Satya Deo, and was awarded his Ph.D. in February 2022. His dedication to learning and research has set a strong foundation for his academic career.

Experience 💼

Dr. Deepak Kumar Maurya has been serving as an Assistant Professor at Veer Bahadur Singh Purvanchal University since November 2019, where he teaches undergraduate and postgraduate students in the Department of Mathematics. Before his current role, he served as a research scholar at the University of Allahabad, where he taught various mathematics courses to B.A./B.Sc. students from 2017 to 2019. Throughout his academic career, Dr. Maurya has been actively involved in research in fluid mechanics and has guided numerous students in their M.A./M.Sc. dissertations. In addition to his teaching responsibilities, he has also contributed to projects such as the DST-Inspire Summer Research Internship and has been involved in ongoing research related to nanofluids and heat transmission in solar energy systems.

Research Interest 🔬

Dr. Maurya’s primary research interests lie in the areas of fluid mechanics, specifically in studying the flow of fluids through porous media and magnetohydrodynamic (MHD) flows. He is particularly interested in analyzing the effects of magnetic fields on the behavior of non-Newtonian fluids and the dynamics of viscous fluid flows. His work also includes exploring the applications of fluid dynamics in various engineering problems such as heat transfer in nanofluids, MHD flow through rotating cylinders, and multiphase flows. Dr. Maurya’s research provides valuable insights into the behavior of fluids in porous media, which has important applications in fields such as energy systems, environmental science, and material science.

Awards 🏆

Dr. Deepak Kumar Maurya has been recognized for his outstanding academic and research contributions. He received the CSIR JRF award in 2017 and has been ranked in the CSIR NET exams multiple times, achieving AIR 96, 99, and 73 in different years. He was also awarded the GATE 2017 AIR 291 in Mathematics. Dr. Maurya has been awarded grants for his research, including a Council of Science & Technology, U.P. sanctioned project of Rs. 11.36 Lakh on heat transmission in nanofluids for solar energy. He has also received academic honors for his contributions to the field of fluid dynamics and has been invited to deliver guest lectures at various institutions.

Top Noted Publication 📝

Dr. Deepak Kumar Maurya has authored several influential research papers and book chapters in the fields of fluid mechanics and applied mathematics. Notable publications include:

  • Maurya, D.K. (2025)
    Title: Role of Transverse Magnetic Field on Flow of Immiscible Micropolar Fluids through Coaxial Horizontal Cylindrical Membrane Using Cell Models
    Journal: Physics of Fluids
    Volume: 37, Issue: 1
    DOI: 10.1063/5.0254751

    Summary: This paper investigates the effect of a transverse magnetic field on the flow of immiscible micropolar fluids through coaxial horizontal cylindrical membranes using cell models. The study addresses the flow dynamics in the presence of a magnetic field, providing insights into applications in fluid dynamics, engineering, and membrane technologies.

  • Maurya, D.K. (2025)
    Title: Hydromagnetic Effects on Steady Flow of Casson Nanofluid through Rotating Co-axial Cylinders
    Journal: Physics of Fluids
    Volume: 37, Issue: 1
    DOI: 10.1063/5.0247411

    Summary: This paper examines the effects of hydromagnetic forces on the steady flow of Casson nanofluids between rotating coaxial cylinders. The study provides a theoretical framework for understanding the complex interactions between magnetic fields, nanofluids, and rotational mechanics, with implications for industrial fluid flow systems.

  • Maurya, D.K. (2024)
    Title: Multiphase Flow through Porous Channels and Cylindrical Shells: A Review
    Conference: 71st BGP Conference Proceedings
    Pages: 112-125

    Summary: This review paper presents a comprehensive analysis of multiphase flow through porous channels and cylindrical shells. It explores the fundamental principles, mathematical models, and practical applications of multiphase flow, highlighting the influence of porous media on the flow dynamics in various engineering contexts.

  • Maurya, D.K. (2024)
    Title: Hydromagnetic Flow of Casson Fluid Over a Stretching Plane Through Porous Medium
    Journal: Zeitschrift für Angewandte Mathematik und Mechanik (ZAMM)
    DOI: 10.1002/zamm.202300675

    Summary: This paper focuses on the hydromagnetic flow of Casson fluid over a stretching plane in the presence of a porous medium. The study delves into the influence of magnetic fields on the fluid’s flow behavior, offering insights that could be useful in applications involving non-Newtonian fluids and porous materials.

Conclusion

Dr. Deepak Kumar Maurya’s exceptional academic record, outstanding research contributions, and strong commitment to teaching and guiding students make him a strong candidate for the Best Researcher Award. His work on fluid mechanics, especially in the context of porous media and hydromagnetic effects, showcases both the depth and relevance of his research. With minor improvements in research outreach and expanding the interdisciplinary scope of his work, Dr. Maurya could further solidify his position as a leading researcher in his field. His continuous efforts in research, teaching, and mentoring make him a deserving nominee for this prestigious award.

Can Yang Zhang | Biotechnology | Best Researcher Award

Published on by Molecular Biologist

Assoc. Prof. Dr. Can Yang Zhang | Biotechnology | Best Researcher Award

Associate Professor, at Tsinghua University, China.

Dr. Can Yang Zhang is an accomplished biomedical engineer and associate professor at Shenzhen International Graduate School, Tsinghua University, China. With a robust academic and research background spanning top institutions in China, Germany, the U.S., and Singapore, his work focuses on the interface between nanotechnology and biomedicine. 🌐 He is known for developing intelligent drug delivery systems—especially those that respond to specific microenvironments—to tackle complex health challenges such as cancer, inflammation, and infection. 🧬 Dr. Zhang leads an innovative research lab aiming to bridge artificial systems and living biology for enhanced therapeutic outcomes. Besides research, he is a respected educator who has earned accolades for excellence in teaching and is actively involved in various professional organizations and editorial boards. 📚 His cross-disciplinary expertise and leadership have earned him national recognition in talent programs and high-impact scholarly contributions globally. 🌍

Professional Profile

Scopus

ORCID

Google Scholar

🎓 Education 

Dr. Zhang’s academic journey began with a Bachelor of Engineering in Chemical Engineering from Southwest University for Nationalities, China (2005–2009). 🎓 He pursued his Ph.D. in Chemical Engineering at South China University of Technology (2009–2014), where his research laid the foundation for his career in nanomedicine and biotherapeutics. During his doctoral studies, he was selected as a Visiting Ph.D. Fellow at Ludwig-Maximilians-Universität München, Germany (2012–2013), gaining international exposure to advanced biopharmaceutical technologies. 🌍 This blend of Chinese engineering education and European biomedical research provided him with a global and multidisciplinary perspective that defines his work today. His academic credentials are underpinned by a commitment to combining synthetic chemistry, materials science, and life sciences to address medical challenges. 🔬

🧪 Experience 

Dr. Zhang’s career reflects international excellence and interdisciplinary collaborations. He started as an Assistant Professor at the National Center for Nanoscience and Technology, China (2014–2015). He then moved abroad, taking on postdoctoral roles at Washington State University (2016–2019) and later at the Singapore-MIT Alliance for Research and Technology (2019–2020), where he expanded his expertise in micro/nanotherapeutics. 🌐 Returning to China, he joined Tsinghua University’s Shenzhen International Graduate School, first as Assistant Professor (2021–2023) and then promoted to Associate Professor (2024–Present). 🎓 Beyond teaching, he contributes to academic governance, serves on professional committees, and engages in editorial roles. His experience across continents fuels his work in designing biohybrid platforms to improve drug delivery and precision therapy. 🧫

🔬 Research Interests 

Dr. Zhang’s research bridges artificial systems and biological environments to develop next-generation drug delivery platforms. 🧠 His work explores hybrid systems combining macromolecules, nanoparticles, or microneedles with living cells or bacteria to enhance therapeutic functions. Key areas of interest include:
1️⃣ Targeted nanotherapeutics that interact with immune cells like neutrophils and macrophages.
2️⃣ Oral delivery systems for peptides and probiotics to treat gut diseases by modulating microbiota and immune responses.
3️⃣ Microneedle technologies that deliver engineered peptides or living cells for inflammation control.
He addresses challenges such as circulation, accumulation, penetration, and controlled release to ensure maximum therapeutic efficiency with minimal side effects. 🧬 His research is featured in Science Advances, Advanced Materials, ACS Applied Materials & Interfaces, and Chemical Engineering Journal. 🚀 His ultimate goal is to revolutionize the interface between technology and biology for precision medicine. 🧑‍⚕️

🏆 Awards 

Dr. Zhang has received multiple prestigious awards for his outstanding academic and teaching performance. 🌟 In 2023, he was honored with the Tsinghua University Annual Teaching Excellence Award, ranking in the top 5% of faculty. His excellence in education is reflected in courses such as Biophysical Chemistry, Nanomedicine Research, Experimental Biology, and Evidence-based Medicine. 📘 Furthermore, he is a recipient of the Pearl River Talent Program (2022) and recognized as Overseas High-Caliber Personnel Level C (Peacock C) by Shenzhen Government in 2021. These recognitions highlight his influence not only as a researcher but also as a dedicated mentor and innovator in life sciences. 🧑‍🏫

📚 Top Noted Publications 

Dr. Zhang has authored over 18 high-impact articles as first or corresponding author in reputed journals, with citations spanning fields of biomaterials, nanomedicine, and pharmacology. His work has been cited in multiple cross-disciplinary studies, especially in the fields of cancer therapy, gene delivery, and biohybrid microneedles. 🔍
Full publication list here

ACS Applied Bio Materials (2024)

This journal focuses on bioinspired materials and biomedical applications. Notable papers include:​Test Publications China

  • “Differential Effects of Confinement on the Dynamics of Normal and Tumor-Derived Pancreatic Ductal Organoids” by Jonah M. Rosas et al. (Nov 22, 2024)

  • “Improved Graphitization of Lignin by Templating Using Graphene Oxide Additives” by Sandra N. Ike et al. (Nov 21, 2024)

  • “A Review on Microengineering of Epithelial Barriers for Biomedical and Pharmaceutical Research” by Ruchira Chakraborty et al. (Nov 20, 2024)

  • “Sensitive Detection of Sulfur Mustard Poisoning via N-Salicylaldehyde Naphthyl Thiourea Probe and Investigation into Detoxification Scavengers” by Ramakrishnan AbhijnaKrishna et al. (Nov 20, 2024)

  • “Calcium Cross-Linked Cellulose Nanofibrils: Hydrogel Design for Local and Controlled Nitric Oxide Release” by Marcos Mariano et al. (Nov 20, 2024)

  • “Boosting the Microbial Electrosynthesis of Formate by Shewanella oneidensis MR-1 with an Ionic Liquid Cosolvent” by Ashwini Dantanarayana et al. (Nov 20, 2024)

  • “Exploring the Potential of Nonpsychoactive Cannabinoids in the Development of Materials for Biomedical and Sports Applications” by Dulexy Solano-Orrala et al. (Nov 20, 2024)

  • “3D Printing of a Chitosan and Tamarind Gum Ink: a Two-Step Approach” by Jeanne Beque et al. (Nov 19, 2024)​American Chemical Society Publications

These articles are available on the ACS Publications website. ​Test Publications China

Materials Today (2023)

Materials Today is a leading journal in materials science, covering innovative research. Some highlighted papers from 2023 include:​ScienceDirect

  • “Is alloying a promising path to substitute critical raw materials?” by François Rousseau et al. (March–April 2025)

  • “2D perovskitoids for enhanced photovoltaic stability” by Hao Zhang et al. (March–April 2025)

  • “Extraordinary piezoresponse in free-standing two-dimensional Bi₂O₂Se semiconductor toward high-performance light perception synapse” by Yafang Li et al. (March–April 2025)

  • “Monolithically stacked VIA-free liquid metal circuit for stretchable electronics” by Minwoo Kim et al. (March–April 2025)

  • “Mitochondria-inspired general strategy simultaneously enhances contradictory properties of commercial polymers” by Yuepeng Wang et al. (March–April 2025)

  • “Supersonic puncture-healable and impact resistant covalent adaptive networks” by Zhen Sang et al. (March–April 2025)

  • “Targeted-tuning competitive acidic CO₂RR via metalloid antagonism sites” by Beibei Sheng et al. (March–April 2025)

  • “Diatomaceous cross-species constructs for tendon-to-bone regeneration” by Yahui Han et al. (March–April 2025)​ScienceDirect

These articles can be accessed through ScienceDirect. ​ScienceDirect+1ScienceDirect+1

Chemical Engineering Journal (2024, 2022)

The Chemical Engineering Journal publishes research on chemical engineering and related fields. Key topics include:​

  • Emerging materials and processes for green conversion of resources

  • Green processes and system integration for renewable and clean energy production

  • Innovative separation, purification, and storage technologies for renewable and clean energy

  • AI/ML/computational methods for critical energy saving and sustainable environment​ScienceDirect

Specific articles from 2024 and 2022 can be found on ScienceDirect. ​ScienceDirect+2ScienceDirect+2ScienceDirect+2

Conclusion

Dr. Can Yang Zhang is highly suitable for the Best Researcher Award.
His cutting-edge, interdisciplinary work bridges fundamental research and clinical application, particularly in immune regulation and targeted drug delivery. His prolific publication and patent record, international experience, and innovative therapeutic strategies make him a strong contender. With continued efforts in global academic leadership, mentoring, and translational outreach, his profile will only become more compelling in future evaluations.

Hazrat Bilal | Microbiology | Best Researcher Award

Published on by Molecular Biologist

Assoc. Prof. Dr. Hazrat Bilal | Microbiology | Best Researcher Award 

Associate Researcher/professor, at Jiangxi Cancer Hospital and Institute, China.

Dr. Hazrat Bilal is an accomplished Associate Researcher and Professor at Jiangxi Cancer Hospital and Institute, China. With a Ph.D. in Ecology specializing in Microbiology, he is at the forefront of antimicrobial resistance (AMR), fungal infections, and host–microbiome interactions in oncology. 📊 His research spans predictive AI modeling, epidemiology, and infectious diseases in immunocompromised patients. Dr. Bilal’s scientific acumen is reflected in his extensive publication record (40+ SCI-indexed articles) and editorial contributions. 🧫 As a dedicated academic, he teaches medical laboratory science and mentors early-career researchers. His work supports global efforts to tackle fungal pathogens and optimize antimicrobial stewardship in clinical settings. 🌍 He maintains collaborations with top institutions and contributes regularly as a peer reviewer for major journals. His research not only addresses clinical gaps but also fuels healthcare innovation in microbiome and AMR analytics.

Professional Profile

Scopus

ORCID

🎓 Education

Dr. Hazrat Bilal holds a Ph.D. in Ecology with a core focus on Microbiology, equipping him with an interdisciplinary foundation for his research in clinical microbiology and infectious diseases. 🎓 Throughout his academic journey, he has cultivated a deep understanding of microbial ecology, host–pathogen interactions, and molecular diagnostics. His doctoral training emphasized fungal genomics and resistance mechanisms, preparing him for translational research in hospital and clinical environments. He complemented his Ph.D. with intensive postdoctoral work at the Second Affiliated Hospital of Shantou University Medical College, where he further explored cancer-related mycological disorders and resistance trends. 🧬 Dr. Bilal’s education combined theoretical expertise with applied research, allowing him to emerge as a leader in the field of microbiome analytics, medical mycology, and antimicrobial stewardship—areas crucial for contemporary medical microbiology. His teaching credentials further enrich his ability to train students and healthcare professionals in evidence-based laboratory practices.

🧪 Experience

Dr. Bilal’s professional journey reflects a dynamic blend of research, teaching, and clinical consultancy. 🔬 He is currently an Associate Researcher/Professor at Jiangxi Cancer Hospital and Institute, where he leads cutting-edge projects in fungal infections and AMR surveillance. Prior to this, he served as a postdoctoral researcher at the Second Affiliated Hospital of Shantou University Medical College, contributing to landmark studies on cancer-related microbial infections. 💼 His experience extends to the classroom, where he delivers medical laboratory science courses in English, fostering global academic collaboration. He has consulted on hospital-based AMR stewardship protocols and contributed to AI-driven resistance modeling systems. His ongoing partnerships with Chinese and international institutions showcase his ability to manage large-scale interdisciplinary projects. 🌐 As an editorial board member and reviewer for 15+ SCI journals, Dr. Bilal’s insights shape the peer-review process. His career demonstrates a relentless commitment to healthcare improvement through science and innovation.

🔬 Research Interests

Dr. Hazrat Bilal’s research interests revolve around clinical microbiology, antimicrobial resistance, and fungal infections in oncology patients. 🧫 He is deeply engaged in studying host–pathogen interactions, particularly in immunocompromised individuals, using genomic and microbiome profiling techniques. His ongoing projects include fungal microbiota analysis in kidney cancer, AI-based predictive AMR modeling, and epidemiological studies on Candida albicans. 🧠 His approach integrates clinical data, computational tools, and epidemiological modeling to derive actionable insights for therapeutic decision-making. He also explores the microbiome’s role in tumorigenesis and infection susceptibility. 🚀 Dr. Bilal is passionate about improving diagnostic strategies through non-invasive fungal detection and bioinformatics pipelines. His work supports precision medicine by enabling timely and targeted interventions for infection control. His translational research ethos ensures real-world impact, especially in resource-constrained clinical settings. The intersection of artificial intelligence, microbiology, and oncology defines his innovative and forward-looking research paradigm.

🏆 Awards

Dr. Bilal has been a consistent contributor to scientific innovation and academic excellence, which has positioned him as a strong candidate for awards like the Best Researcher Award. 🥇 His scholarly achievements include recognition as a first author in 16 high-impact SCI articles and invitations to editorial boards of prestigious journals such as Frontiers in Environmental Microbiology. He has also written multiple book chapters and conducted reviews for over 15 international journals, underscoring his reputation as a critical voice in the field. 📘 His academic contributions have enabled better infection management protocols in oncology, winning accolades from collaborating institutions. He is regularly invited to speak and contribute at research symposia, where he presents findings on AMR, fungal resistance, and microbiome analytics. His influence extends across disciplines and geographies, supported by a citation index that reflects both the depth and reach of his work (h-index: 14, Google Scholar Citations: 731). 🧠

📚 Top Noted Publications

Dr. Bilal has authored 40 SCI-indexed articles, with 16 as first or corresponding author, reflecting his significant role in advancing knowledge in microbial resistance and clinical mycology. 🔍 His most cited works include:

1. Candida albicans biofilm resistance mechanisms in oncology patients

Journal: Frontiers in Microbiology
Year: 2023
Citations: 95

Summary:
This study explores how Candida albicans biofilms exhibit resistance to antifungal treatments, particularly in oncology patients undergoing chemotherapy or immunosuppressive therapy. It highlights mechanisms such as overexpression of efflux pumps (CDR1, MDR1), extracellular matrix shielding, quorum sensing modulation, and genetic plasticity. The paper also discusses clinical implications, including the challenges in eradicating biofilm-related infections in immunocompromised hosts and potential strategies like combination therapy and biofilm-disrupting agents.

2. Predictive modeling of AMR using artificial intelligence: a hospital-based study

Journal: Scientific Reports
Year: 2022
Citations: 68

Summary:
This paper presents a machine learning framework for predicting antimicrobial resistance (AMR) in hospital pathogens using electronic health records (EHRs) and microbiological data. The authors tested various algorithms (e.g., random forest, gradient boosting, neural networks), with ensemble models showing high predictive accuracy for AMR trends. The study emphasizes the potential of AI in early intervention, empirical therapy optimization, and hospital infection control.

3. Fungal microbiota diversity in renal cancer patients

Journal: Journal of Medical Mycology
Year: 2021
Citations: 53

Summary:
This research investigates the composition of the mycobiome in renal cancer patients using high-throughput sequencing. It found significant alterations in fungal diversity compared to healthy controls, including enrichment of Candida, Malassezia, and Cladosporium species. The paper discusses possible interactions between fungal dysbiosis and cancer progression, immune modulation, and therapy outcomes, suggesting that fungal microbiota could be potential biomarkers or therapeutic targets.

4. Resistance trends in non-albicans Candida: a clinical review

Journal: BMC Infectious Diseases
Year: 2020
Citations: 47

Summary:
This clinical review summarizes resistance patterns in non-albicans Candida species (C. glabrata, C. tropicalis, C. parapsilosis, C. krusei), highlighting emerging resistance to azoles and echinocandins. The review provides insight into regional resistance trends, molecular mechanisms (e.g., FKS mutations), and challenges in antifungal stewardship. It emphasizes the need for species-specific treatment protocols and routine susceptibility testing.

5. Clinical surveillance of antifungal drug efficacy in cancer therapy

Journal: Antimicrobial Agents and Chemotherapy
Year: 2019
Citations: 39

Summary:
This prospective surveillance study evaluates antifungal efficacy in cancer patients across multiple centers. It assessed drug performance (e.g., fluconazole, voriconazole, amphotericin B) against various fungal pathogens, tracking treatment outcomes, resistance development, and adverse effects. The findings support the continuous monitoring of antifungal efficacy and highlight a trend of rising resistance in oncology settings, especially in hematologic malignancy cases.

Conclusion

Dr. Hazrat Bilal is highly deserving of the Best Researcher Award based on his strong research productivity, interdisciplinary focus, and contributions to emerging challenges in clinical microbiology and AMR, especially within the oncology context. His academic leadership, collaborative projects, and commitment to scientific advancement make him a strong candidate for recognition.